-
Product Insights
Myopia – Drugs In Development, 2023
Global Markets Direct’s, ‘Myopia - Drugs In Development, 2023’, provides an overview of the Myopia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Myopia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Glaucoma Surgery Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Glaucoma Surgery Devices Pipeline Market Report Overview Glaucoma surgery devices are used to augment normal physiologic aqueous outflow pathways to provide effective intra-ocular pressure. Glaucoma drainage devices are designed to divert aqueous humor from the anterior chamber to an external reservoir, where a fibrous capsule forms about 4-6 weeks after surgery and regulates flow. The Glaucoma Surgery Devices pipeline market research report provides comprehensive information about the Glaucoma surgery devices pipeline products with a comparative analysis of the products at...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – IVMED-10
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry IVMED-10 Drug Details Dexamethasone (IVMED-10) is under development for the treatment of post cataract...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – IVMED-20
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry IVMED-20 Drug Details IVMED-20 (dexamethasone) is under development for the treatment of high risk...
-
Product Insights
Keratitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Keratitis is an inflammation of the cornea. Symptoms include eye redness, eye pain, blurred vision, decreased vision, and sensitivity to light. The Keratitis pipeline drugs market research report provides comprehensive information on the therapeutics under development for Keratitis (Ophthalmology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news...
-
Product Insights
Glaucoma Drainage Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021
Glaucoma drainage devices or implants are small plastic devices that are surgically attached to the eye's surface to improve or shunt the flow of aqueous drainage. This segment includes valved drainage devices and non-valved drainage devices. The glaucoma drainage devices pipeline product report provides comprehensive information about the pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The glaucoma drainage devices pipeline report provides detailed insights...
-
Product Insights
Keratoconus Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Keratoconus Global Clinical Trials Review, H2, 2017" provides an overview of Keratoconus clinical trials scenario. This report provides top line data relating to the clinical trials on Keratoconus. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...